Deutsche Bank Ag\ Nuvalent, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Nuvalent, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 35,663 shares of NUVL stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,663

Previous 19,645 81.54%

Holding current value

$2.77 Million

Previous $2.01 Million 38.92%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$77.87 - $104.93 $1.25 Million - $1.68 Million	16,018 Added 81.54%	35,663 $2.79 Million
Q3 2024 Nov 13, 2024	BUY	$67.44 - $112.17 $297,208 - $494,333	4,407 Added 28.92%	19,645 $2.01 Million
Q2 2024 Aug 14, 2024	BUY	$62.76 - $81.61 $39,476 - $51,332	629 Added 4.31%	15,238 $1.16 Million
Q1 2024 May 15, 2024	BUY	$72.35 - $88.99 $32,919 - $40,490	455 Added 3.21%	14,609 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$42.42 - $80.28 $3,860 - $7,305	91 Added 0.65%	14,154 $1.04 Million
Q3 2023 Nov 09, 2023	BUY	$39.12 - $49.85 $87,980 - $112,112	2,249 Added 19.04%	14,063 $646,000
Q2 2023 Aug 14, 2023	SELL	$23.58 - $44.68 $113,254 - $214,598	-4,803 Reduced 28.9%	11,814 $498,000
Q1 2023 May 15, 2023	BUY	$25.42 - $33.52 $129,209 - $170,382	5,083 Added 44.07%	16,617 $433,000
Q4 2022 Feb 13, 2023	BUY	$18.46 - $36.37 $73,489 - $144,788	3,981 Added 52.71%	11,534 $343,000
Q3 2022 Nov 14, 2022	SELL	$13.55 - $19.92 $15,230 - $22,390	-1,124 Reduced 12.95%	7,553 $147,000
Q2 2022 Aug 11, 2022	SELL	$7.4 - $15.07 $12,846 - $26,161	-1,736 Reduced 16.67%	8,677 $118,000
Q1 2022 May 13, 2022	BUY	$11.65 - $19.57 $40,110 - $67,379	3,443 Added 49.4%	10,413 $145,000
Q4 2021 Feb 11, 2022	BUY	$18.01 - $30.1 $6,357 - $10,625	353 Added 5.33%	6,970 $133,000
Q3 2021 Nov 04, 2021	BUY	$18.25 - $38.35 $120,760 - $253,761	6,617 New	6,617 $149,000

Others Institutions Holding NUVL

# of Institutions

232

Shares Held

59M

Call Options Held

834K

Put Options Held

490K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.33B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account